High school students in Billings, Montana recently had the unique opportunity to explore the various career paths available in the healthcare industry. The event, called the Montana BioScience Alliance Careers in Healthcare, aimed to inspire and educate students about the exciting opportunities that await them in the medical field.
Satcher Health Leadership Institute Releases First-Ever Report Demonstrating the Devastating Cost of Mental Health Inequities
SHLI looked at a four-year period (2016-2020) and found, at minimum, nearly 117,000 lives and approximately $278 billion could have been saved. The full report will be released and available for download in the coming days.
Golden Helix Receives New NIH SBIR Grant
Golden Helix, Inc. of Bozeman, MT has been awarded the NIH SBIR Grant 1R43HG013456-01 “Pharmacogenomics Workflow: Identifying Biomarkers and Treatment Options.”
Montana State RNA editing research featured in new publication
New technology developed by researchers at Montana State University, featured this month on the cover of the journal Science Advances, could have powerful impacts on the way scientists study viruses, make vaccines or splice genes.
Led by sciences and engineering, Montana State research spending hits record $230 million
For a fifth straight year, Montana State University recorded an all-time high for research expenditures — the funding put toward scientific discovery and other scholastic and creative pursuits. MSU is the largest research enterprise in the state, and its total expenditures exceed the research expenditures of all other institutions in the state combined.
Central Montana Medical Center begins $15.6 million cancer center project
Central Montana Medical Center has broken ground on a $15.6 million cancer center that will bring comprehensive cancer care services to central Montana. That means residents living in central and northern Montana won’t have to travel as long for cancer treatment.
University of Montana working on vaccine for fentanyl, heroin overdose
A vaccine to prevent overdosing on fentanyl and one for heroin are in the works at the University of Montana and partner institutions. Human trials are expected to start in early 2024 for both vaccines, according to UM.
NCI SBIR Grants and Funding Opportunities Announced
Are you working to develop an innovative cancer technology? Take a step forward in your commercialization journey through the newly released FY2024 SBIR Contract Solicitation! This funding opportunity aims to provide early-stage funding to small businesses that are developing cancer technologies in areas defined by the National Cancer Institute.